Cargando…

COVID19 seroconversion in an unrelated stem cell donor

Detalles Bibliográficos
Autores principales:	Maakaron, Joseph E., McKenna, David, El-Jurdi, Najla, Arora, Mukta, Brunstein, Claudio, Devine, Steven, Yohe, Sophia, Weisdorf, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507593/ https://www.ncbi.nlm.nih.gov/pubmed/32963335 http://dx.doi.org/10.1038/s41409-020-01066-z

Ejemplares similares

High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group
por: El Jurdi, Najla, et al.
Publicado: (2021)

Impact of COVID-19 pandemic on global unrelated stem cell donations in 2020—Report from World Marrow Donor Association
por: Jöris, Monique M., et al.
Publicado: (2022)

A DKMS (German Bone Marrow Donor Center) view on cryopreservation of unrelated donor stem cell products during the Covid‐19 pandemic
por: Schmidt, Alexander H., et al.
Publicado: (2021)

The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage
por: Szer, Jeff, et al.
Publicado: (2020)

Mismatched unrelated donor allogeneic stem cell transplant for high risk haematological malignancy: A single centre experience
por: Mediwake, Heshani, et al.
Publicado: (2017)

Temporal variation in oral microbiome composition of patients undergoing autologous hematopoietic cell transplantation with keratinocyte growth factor
por: Bohn, Bruno, et al.
Publicado: (2023)

Seroconversion in household members of COVID-19 outpatients
por: Cox, Rebecca J, et al.
Publicado: (2021)

Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type
por: Mehta, Rohtesh S., et al.
Publicado: (2023)

Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies
por: Raghunandan, Sharmila, et al.
Publicado: (2023)

Computer Algorithms in the Search for Unrelated Stem Cell Donors
por: Steiner, David
Publicado: (2012)

Management of psychiatric complications in unrelated donor before unrelated peripheral hematopoietic stem cell collections
por: Hequet, Olivier, et al.
Publicado: (2016)

Higher Therapeutic Cyclosporine Levels Early Post-Transplantation Reduces Risks of Acute Graft-Versus-Host Disease and Improves Survival
por: Rogosheske, John R., et al.
Publicado: (2013)

IFNL4 and donor selection for matched unrelated donor haematopoietic stem-cell transplantation
por: Westervelt, Peter
Publicado: (2020)

Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical donor?
por: Perales, Miguel-Angel, et al.
Publicado: (2020)

COVID-19 Seroconversion in Emergency Professionals at an Urban Academic Emergency Department in New York City
por: Jeong, Jordan M., et al.
Publicado: (2020)

Recruiting unrelated donors for the National Marrow Donor Program.
por: Yanke, D. R.
Publicado: (1990)

Unrelated Hematopoietic Stem Cell Donor Matching Probability and Search Algorithm
por: Tiercy, J.-M.
Publicado: (2012)

Support of Unrelated Stem Cell Donor Searches by Donor Center-Initiated HLA Typing of Potentially Matching Donors
por: Schmidt, Alexander H., et al.
Publicado: (2011)

Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medications
por: Levit, Elle, et al.
Publicado: (2022)

Suicide prevention during the COVID-19 outbreak
por: Klomek, Anat Brunstein
Publicado: (2020)

Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products
por: Auletta, Jeffery J., et al.
Publicado: (2021)

Alternative Donor Transplantation for Acute Myeloid Leukemia
por: Bejanyan, Nelli, et al.
Publicado: (2015)

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors
por: Pulsipher, Michael A., et al.
Publicado: (2019)

SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry
por: Pryce, Angharad, et al.
Publicado: (2021)

Positive Bubble Study in Severe COVID-19: Bubbles May Be Unrelated to Gas Exchange Impairment
por: Swenson, Erik R., et al.
Publicado: (2021)

Losing the genetic twin: donor grief after unsuccessful unrelated stem cell transplantation
por: Wanner, Martina, et al.
Publicado: (2009)

The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children
por: Park, Meerim, et al.
Publicado: (2011)

Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease
por: Schuetz, C., et al.
Publicado: (2008)

Ongoing Risk of Unrelated Donors Testing Positive for COVID-19 Following Medical Clearance and Impact on Operations: A Report from the National Marrow Donor Program
por: Stefanski, Heather E., et al.
Publicado: (2023)

Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States
por: Subramanian, S. V., et al.
Publicado: (2021)

Autoimmune hematological diseases following haploidentical donor hematopoietic stem cell transplant compared with matched sibling and unrelated donor
por: Lv, Weiran, et al.
Publicado: (2017)

5 years DKMS Chile: approach, results and impact of the first unrelated stem cell donor center in Chile
por: Barriga, Francisco, et al.
Publicado: (2023)

Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak among pediatric oncology patients
por: Mayanskiy, Nikolay, et al.
Publicado: (2021)

Reduction of Relapse after Unrelated Donor Stem Cell Transplantation by KIR-Based Graft Selection
por: Heidenreich, Silke, et al.
Publicado: (2017)

Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes
por: Herzog, Shannon, et al.
Publicado: (2023)

Donor-derived mycosis fungoides following reduced intensity haematopoietic stem cell transplantation from a matched unrelated donor
por: Kinsella, Francesca A M, et al.
Publicado: (2017)

Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate
por: El Jurdi, Najla, et al.
Publicado: (2023)

HIV Seroconversion in blood donors from the coordinating blood bank in the State of Pará
por: Costa, Andrea Silvestre Lobão, et al.
Publicado: (2011)

Related versus unrelated allogeneic HPC graft cryopreservation: a single-center experience in the context of the global COVID-19 pandemic
por: Mfarrej, B., et al.
Publicado: (2021)

Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling
por: Anurathapan, Usanarat, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3n9cjd643mohmialqf232d85mc